Prosecution Insights
Last updated: October 25, 2026

Casimir Jones, S.C.

Technology area: Biotechnology & Pharmaceuticals

354 pending office actions • 151 clients • 289 examiners • 120 art units • 0 of 354 (0%) have an AI response strategy ready

Analysis

Casimir Jones, S.C. has 348 pending office actions in Biotechnology & Pharmaceuticals and 11164 career applications. The pending docket and application history both show substantial activity in this technology area, giving practitioners a meaningful basis for evaluating prosecution capacity and experience.

The resolved allowance rate is 80.65%, with an average of 4.15 office actions per allowance. The allowance measure describes the firm’s recorded success in resolved matters, while the action average indicates that allowances are associated with repeated examination activity. Applicants should account for that interaction when planning claim amendments, response schedules, and expected prosecution effort.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=11164 apps, methodology: how we score firms)

80.6%
Allowance Rate
n=11164
+0.76σ
Allowance Rate (norm)
n=11164
4.2
OAs to Allowance
n=5073
+0.02σ
OAs to Allow (norm)
n=5073
1124 days
Time to Allowance
n=5073
+16.2pp
Interview Lift
n=11164
39.0%
RCE Rate
n=11164
1.4%
Appeal Rate
n=11164

Rejection Performance (% of received rejections ultimately overcome)

74.1%
§101 Overcome
n=979
69.1%
§102 Overcome
n=2785
69.6%
§103 Overcome
n=4008
74.1%
§112 Overcome
n=4105

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
32%
Top-3 CPC Share
n=11164
10
Practitioners
n=11164
1116.4
Apps / Practitioner
n=11164

Portfolio Summary

354
Total Pending OAs
225
Non-Final OAs
123
Final Rejections
6
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 105 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

45
Overdue
4
Due this week
30
Due this month
17
Due in next 60 days
9
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 105 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (45)Due ≤ 7 days (4)Due ≤ 30 days (30)Due ≤ 60 days (17)Due later (9)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

185
Hard (52%)
129
Medium (36%)
37
Easy (10%)
3
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only6 (2%)
§101 + other46 (13%)
§103 only88 (25%)
§102 only12 (3%)
§112 only26 (7%)
Double-patenting only11 (3%)
Double-patenting + other29 (8%)
Multi-statute (no §101)133 (38%)
No statute on record3 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

285
Life Sciences
81% of docket
2
Information Tech
1% of docket
7
Communications
2% of docket
9
Semiconductors
3% of docket
47
Mechanical / Eng
13% of docket
4
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

3,540 h
Manual time on pending OAs
708 h
Time saved (low, 20%)
1,239 h
Time saved (mid, 35%)
31.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SALMON, KATHERINE D 5 42.9% +37.7%
EBBINGHAUS, BRIANA NOEL 3 59.7% +63.0%
SU, STEPHANIE T 3 67.3% +28.7%
CHUNDURU, SURYAPRABHA 3 53.3% +17.2%
BOWERS, ERIN M 3 54.7% +9.8%
HINES, JANA A 3 53.2% +39.4%
GOLDBERG, JEANINE ANNE 3 45.4% +40.5%
FRITCHMAN, REBECCA M 3 45.6% +35.4%
DABKOWSKI, ERINNE R 3 55.8% +68.7%
BERTOGLIO, VALARIE E 2 64.1% +30.3%

Hard Cases (185)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17923671 FLUID INJECTION DEVICE FOR INJECTING A FLUID BEHIND THE TYMPANIC MEMBRANE DAVIS, JASON GREGORY 167d overdue
17920698 INHIBITION OF SARS-COV-2 VIRAL ENTRY THROUGH ORAL ADMINISTRATION OF LACTOFERRIN AND USES THEREOF BRADLEY, CHRISTINA 162d overdue
17768274 COMPOUNDS FOR IMMUNOMODULATION MIANO, JOSEPH PAUL 146d overdue
17906471 T-CELL BISPECIFIC BINDING PROTEINS OGUNBIYI, OLUWATOSIN A 126d overdue
17764850 IgE Antibody with Fcgamma Receptor binding SANG, HONG 100d overdue
17630568 ELECTRONIC HAIL PAD ISLAM, MOHAMMAD K 89d overdue
17549028 PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE ZHU, JIANJIAN 44d overdue
18004082 BIOMATERIAL COMPRISING BACTERIAL CELLULOSE AND PROBIOTICS AND USES THEREOF HINES, JANA A 36d overdue

Interview Candidates (28)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18425731 PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS HINES, JANA A 119d overdue
17727128 DETECTING ESOPHAGEAL DISORDERS GOLDBERG, JEANINE ANNE 104d overdue
18313856 COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS DABKOWSKI, ERINNE R 37d overdue
18004082 BIOMATERIAL COMPRISING BACTERIAL CELLULOSE AND PROBIOTICS AND USES THEREOF HINES, JANA A 36d overdue
18245660 METHODS AND COMPOSITIONS FOR REMOVAL OF RNA SALMON, KATHERINE D 5d overdue
17266897 TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS DABKOWSKI, ERINNE R 2d overdue
18147094 USE OF BIOMARKERS TO DETERMINE SUB-ACUTE TRAUMATIC BRAIN INJURY (TBI) IN A SUBJECT HAVING RECEIVED A HEAD COMPUTERIZED TOMOGRAPHY (CT) SCAN THAT IS NEGATIVE FOR A TBI OR NO HEAD CT SCAN FRITCHMAN, REBECCA M 27d
18027764 MARKERS FOR DETECTING CARDIOVASCULAR DISEASE AND CARDIOVASCULAR DISEASE RISK FRITCHMAN, REBECCA M 69d

Client Portfolio (151 clients)

View all 151 →

Top Art Units

Art UnitApps
168219
168112
167511
16319
16439
16328
16728
16387
16457
16837

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19576555 COMPOSITIONS AND METHODS FOR OBTAINING HUMAN INTESTINAL TISSUE AND RELATED USES THEREOF The Regents of the University of Michigan BERTOGLIO, VALARIE E 1632 §101§102 Final Rejection — Pending Mar 24, 2026
19431465 COMPOSITIONS, METHODS, AND SYSTEMS FOR RELATED TO HIGH-DENSITY VERTICAL FARMING Beanstalk, Inc. EVANS, EBONY E 3647 §102§103§112 Final Rejection — Pending Dec 23, 2025
19426765 PROCESS FOR PRODUCING BETA-LACTOGLOBULIN ISOLATES AND RELATED METHODS AND USES Arla Foods Amba TRAN, LIEN THUY 1793 §103§112DP Non-Final OA — Pending Dec 19, 2025
19374947 COMPOSITIONS AND METHODS FOR OBTAINING HUMAN INTESTINAL TISSUE AND RELATED USES THEREOF The Regents of the University of Michigan BERTOGLIO, VALARIE E 1632 DP Final Rejection — Pending Oct 30, 2025
19327016 SINGLE TOUCH CONTACT LENS PACKAGE Johnson & Jonhson Vision Care, Inc. ORTIZ, RAFAEL ALFREDO 3736 §102§103§112 Non-Final OA — Pending Sep 12, 2025
19161361 PATIENT SUPPORT BOARD Leo Cancer Care, Inc. PATEL, TARLA R 3786 §102§103 Non-Final OA — Pending Sep 02, 2025
19300288 CORNER STRUCTURE OF GLASS RUN AND METHOD OF MANUFACTURING CORNER STRUCTURE Nishikawa Rubber Co., Ltd. STRIMBU, GREGORY J 3634 §103§112 Final Rejection — Pending Aug 14, 2025
19147007 COMPOSITIONS COMPRISING SUPRAMOLECULAR ASSEMBLIES OF PEPTIDE AMPHIPHILES AND ORGANIC CATIONS AND METHODS OF USE THEREOF Northwestern University KELLY, ROBERT M 1638 §102§112 Non-Final OA — Pending Jul 10, 2025
19259540 SLIDING BIOACTIVE PEPTIDES FOR THERAPEUTIC DELIVERY Northwestern University ALLEN, MARIANNE P 1647 §112 Final Rejection 14d Pending Jul 03, 2025
19259714 HUMAN SPINAL CORD INJURY ORGANOIDS Northwestern University EBBINGHAUS, BRIANA NOEL 1632 §101§102§103§112DP Non-Final OA — Pending Jul 03, 2025
19249689 PATIENT POSITIONING SYSTEM Leo Cancer Care, Inc. SANTOS, ROBERT G 3673 §102§103§112Other Final Rejection — Pending Jun 25, 2025
19233435 LOCALIZED GENERATIVE ARTIFICIAL INTELLIGENCE FOR AUTONOMOUS DRIVING WITH WORLD MODEL Cavh LLC MARTINEZ BORRERO, LUIS A 3665 Other Non-Final OA — Pending Jun 10, 2025
19231650 RESTORATION AND ELEVATION FOR VEHICLE DRIVING INTELLIGENCE Cavh LLC REDHEAD JR., ASHLEY L 3661 §103 Non-Final OA — Pending Jun 09, 2025
19226996 ANASTOMOSIS FORMATION WITH MAGNETIC DEVICES HAVING TEMPORARY RETENTION MEMBER Gt Metabolic Solutions, Inc. DAVID, SHAUN L 3771 §103§112DP Non-Final OA — Pending Jun 03, 2025
19209521 SYSTEMS AND METHODS FOR ASSESSING EJECTION FRACTION, HEART FAILURE, AND SLEEP APNEA USING ELECTROCARDIOGRAPHIC SIGNALS Peerbridge Health, Inc. MUTCHLER, CHRISTOPHER JOHN 3796 §101§102§103§112 Non-Final OA — Pending May 15, 2025
19128886 COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING A DNA MODIFICATION UMC Utrecht Holding B.V. TOKARCZYK, CHRISTOPHER B 3687 §102§103§112 Non-Final OA — Pending May 09, 2025
19191852 COMPOSITIONS AND METHODS FOR TREATING KIDNEY STONES The Regents of the University of Michigan LONDON, STEPHEN FLOYD §102§103§112 Non-Final OA — Pending Apr 28, 2025
19177055 SYSTEMS AND METHOD FOR IMPROVING HEALTHY LONGEVITY ("HEALTHSPAN") FIELDS Evity Technologies, Inc. SOREY, ROBERT A 3682 §101§112 Final Rejection — Pending Apr 11, 2025
19177062 INCENTIVIZATION SYSTEMS FOR CURATION OF ARTIFICIAL INTELLIGENCE SYSTEMS Evity Technologies, Inc. PATEL, DIVESH 3696 §101§102§103 Non-Final OA — Pending Apr 11, 2025
19175167 DEVICES AND METHODS FOR ASSISTING MAGNETIC COMPRESSION ANASTOMOSIS Gt Metabolic Solutions, Inc. TANNER, JOCELIN C 3771 §102§103Other Non-Final OA — Pending Apr 10, 2025
19120162 IMPLANTABLE SCAFFOLDS AND METHODS OF USE The University of North Carolina at Chapel Hill AL-AWADI, DANAH J 1615 §103§112 Non-Final OA — Pending Apr 10, 2025
19119530 KNITTED FABRIC AND ATTACHMENT USING SAID KNITTED FABRIC Okamoto Corporation HUANG, GRACE 3732 §102§103 Final Rejection — Pending Apr 09, 2025
19090669 AUTOMATED DRIVING CLOUD SYSTEM FOR LONG-TAIL CORNER CASES Cavh LLC ISMAIL, MAHMOUD S 3662 §112DP Final Rejection — Pending Mar 26, 2025
19113074 DUAL SCINTILLATOR SYSTEM FOR NEUTRON AND ELECTROMAGNETIC IMAGING Shine Technologies, LLC KAO, CHIH CHENG G 2884 §102§103§112 Non-Final OA — Pending Mar 19, 2025
19112886 METHODS, DEVICES, AND SYSTEMS FOR TREATING BONE DEFECTS The Regents of the University of Michigan LAWSON, MATTHEW JAMES 3619 §102§103 Non-Final OA — Pending Mar 18, 2025
19111989 FREQUENCY BASED RIG ANALYSIS Exebenus AS QUAIM, LAMIA 3676 §101 Final Rejection — Pending Mar 14, 2025
19108219 PHOTOCLEAVAGE OF INDICAN Danmarks Tekniske Universitet KHAN, AMINA S 1761 §101§102§103§112 Non-Final OA — Pending Mar 03, 2025
19067465 COMPOSITIONS AND METHODS RELATED TO GENE STACKING SYSTEMS North Carolina State University STEPHENS, AMELIA CAROLE 1645 §102§103§112 Non-Final OA — Pending Feb 28, 2025
19065311 PROACTIVE SENSING SYSTEMS FOR AUTOMATED DRIVING SYSTEMS Cavh LLC POPE, DARYL C 2686 DP Non-Final OA — Pending Feb 27, 2025
19057621 CLOUD-BASED AUTOMATED DRIVING SYSTEM FOR ADVERSE WEATHER CONDITIONS Cavh LLC EL CHANTI, HUSSEIN A 3669 DP Final Rejection — Pending Feb 19, 2025
19040053 METHOD AND SYSTEM FOR EMERGENCY MONITORING AND ACTING IN DOMESTIC ENVIRONMENTS Telefonica Innovacion Digital, S.L.U. GARCIA, CARLOS E 2686 §103 Final Rejection — Pending Jan 29, 2025
18998013 RECORD SUPPORT PLATE, RECORD JACKET, AND RECORD PRODUCT P-Vine, Inc. KLIMOWICZ, WILLIAM JOSEPH 2688 §102§103 Non-Final OA — Pending Jan 23, 2025
19027927 SYSTEM AND METHOD FOR AN AUTOMATED HEALTHCARE INSURANCE CLAIM DENIAL APPEAL USING INTEGRATED ARTIFICIAL INTELLIGENCE AND CLINICIAN REVIEW Authsnap, Inc. PATEL, AMIT HEMANTKUMAR 3696 §101 Non-Final OA — Pending Jan 17, 2025
19030131 SYSTEM AND METHOD FOR SINGLE MOLECULE DETECTION Arizona Board of Regents NOGUEROLA, ALEXANDER STEPHAN 1795 §103§112Other Non-Final OA — Pending Jan 17, 2025
19022747 DEVICES AND METHODS FOR ASSISTING MAGNETIC COMPRESSION ANASTOMOSIS Gt Metabolic Solutions, Inc. TANNER, JOCELIN C 3771 §102 Final Rejection 78d overdue Pending Jan 15, 2025
18994414 COMPOSITIONS AND METHODS FOR GROWING ESOPHAGEAL CELLS AND RELATED USES THEREOF The Regents of the University of Michigan MIANO, JOSEPH PAUL 1631 §101§102§103§112 Non-Final OA — Pending Jan 14, 2025
19020225 VEHICLE SAFETY SYSTEM FOR AUTONOMOUS DRIVING Cavh LLC SU, STEPHANIE T 3662 §103 Final Rejection — Pending Jan 14, 2025
19019000 VEHICLE-BASED CLOUD COMPUTING SYSTEM FOR AUTONOMOUS DRIVING Cavh LLC SU, STEPHANIE T 3662 §103 Final Rejection — Pending Jan 13, 2025
19016469 NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF BAYER AKTIENGESELLSCHAFT RAMIREZ, DELIA M 1652 §102§103 Non-Final OA — Pending Jan 10, 2025
19012368 COMPOSITIONS AND METHODS FOR OBTAINING VASCULARIZED HUMAN INTESTINAL ORGANOID TISSUE, AND RELATED USES THEREOF The Regents of the University of Michigan RAHMAN, MASUDUR 1633 §112 Non-Final OA — Pending Jan 07, 2025
19011131 VEHICLE COMPUTING SYSTEM FOR AUTONOMOUS DRIVING Cavh LLC SU, STEPHANIE T 3662 §103§112 Final Rejection — Pending Jan 06, 2025
19008900 BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS UNIVERSITY OF MARYLAND, BALTIMORE WAX, ROBERT A 1615 §102§103§112 Non-Final OA — Pending Jan 03, 2025
18990320 SEPARABLE BI-DIRECTIONAL CHECK VALVE ASSEMBLY Luminoah, Inc. COLON MORALES, DAVID 3753 §103 Final Rejection 27d Pending Dec 20, 2024
18987112 GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY Abbott Laboratories FARDANESH, MARJAN 3791 §102 Non-Final OA — Pending Dec 19, 2024
18984181 DETECTION OF PHARMACEUTICAL PRODUCT FREEZING HISTORY USING WATER PROTON NMR UNIVERSITY OF MARYLAND, BALTIMORE PATEL, RISHI R 2858 §102§112Other Non-Final OA — Pending Dec 17, 2024
18873153 OPTICAL ELEMENT Osaka University LAVARIAS, ARNEL C 2872 §102§103 Non-Final OA — Pending Dec 09, 2024
18971607 LOW-DOSE TOCILIZUMAB FOR THE TREATMENT OR PREVENTION OF SICKLE CELL CRISIS The University of Chicago HADDAD, MAHER M 1641 §103§112 Non-Final OA — Pending Dec 06, 2024
18970332 METHODS AND COMPOSITIONS FOR WOUND HEALING Wound Engineering LLC LAZARO, DOMINIC 1611 DP Non-Final OA — Pending Dec 05, 2024
18867262 VANADYL SULFATE COMPOSITIONS AND METHODS OF USE THEREFOR FOR THE TREATEMENT AND PREVENTION OF AGING-RELATED DISEASES AND CANCER The University of Chicago CONIGLIO, AUDREA JUNE BUCKLEY 1617 §103§112 Non-Final OA — Pending Nov 19, 2024
18943512 FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD Exact Sciences Corporation BROWN, MINDY G 1683 §112 Non-Final OA 45d overdue Pending Nov 11, 2024

View all 354 →

Managing Casimir Jones, S.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Casimir Jones, S.C.'s patent allowance rate?

80.7% of resolved applications prosecuted by Casimir Jones, S.C. were allowed, across 11,164 applications in USPTO records.

How many office actions does Casimir Jones, S.C. average before allowance?

4.15 office actions per allowed application on average.

How many pending office actions does Casimir Jones, S.C. have?

354 pending office actions as of October 2026, for 151 clients, before 289 examiners in 120 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month